What Novartis' misstep means to investors, plus how Exact Sciences is trying to lock up the genetic testing market.
HEXO could run into some legal troubles soon, and short sellers are eagerly awaiting a drop.
If you don't own these up-and-coming small companies in your investment portfolio yet, you could be missing out on a big opportunity for market-beating returns.
The company's second-quarter revenue is sparking optimism for future growth.
The insulin pump maker's second-quarter financial results are sparking optimism.
These stocks might not be household names, but they could still generate market-beating returns.
Here's what you should know if you want to buy and sell small-cap companies.
Investing in simple businesses like these could be key to market-beating returns.
Owning these big-cap stocks the next time the economy sours could be profit-friendly.
It could be a great time to add these income-friendly stocks to your dividend stock portfolio.
CannTrust growing pot in unlicensed rooms, Gilead Sciences’ deal with Galapagos to develop drugs, and more.
Picking up these five top stocks for portfolios this month could prove profit-friendly.
A recent tumble in marijuana stocks may offer a great buy opportunity.
One of the marijuana industry’s pioneers was just ousted from Canopy Growth. What comes next?
Pot packaging revenue is skyrocketing thanks to marijuana legalization.
Why you ought to consider buying these well-known companies.
These foreign stocks could be great additions to portfolios.
This beer, wine, and spirits leader is benefiting from selling off underperforming brands.
These could be among the fastest-growing shares over that time frame.
It can help high-income earners save a lot of money in retirement.